Sodium phosphate oral solution

This product is an enema, and its main function is to expand the lower intestine and stimulate the defecation reflex, while promoting defecation by increasing the water content of the stool. The LD50 of oral NaH2PO4 in rats is 7.100 mg/kg, and the LD50 of percutaneous NaH2PO4 in rabbits is 7.940 mg/1g, which means that NaH2PO4 is actually very low in toxicity. The LD50 of oral NaH2PO4 in rats is 12.93 mg/kg, which also means that NaH2PO4 is very low in toxicity. Sodium phosphate solution was tested on cats (two dose groups of 18 ml/kg and 32 ml/kg, and the solution was retained in the body for 5 minutes), and all test animals showed abnormal clinical and laboratory indicators.

This product is a compound preparation whose components are sodium dihydrogen phosphate and disodium hydrogen phosphate.

This product is a colorless clear liquid.

No data yet

This product is generally taken twice for intestinal preparation, 45 ml each time. The first dose is at 7 pm the day before the operation or examination. The usage adopts the dilution scheme, and it is taken after diluting with more than 750 ml of warm or cold water. The second dose is at 7 am on the day of the operation or examination, or as prescribed by the doctor, and the usage is the same as the first dose. In order to obtain a good intestinal preparation effect, it is recommended that patients drink more water within their tolerance range.

After taking this product, you may experience nausea, vomiting, bloating, abdominal hernia, diarrhea, fatigue, dizziness, allergic reactions, elevated ALTAST in liver function tests, anal irritation and transient electrolyte disorders (return to normal within hours). Overdose may cause hyperphosphatemia, hypocalcemia, hypokalemia, hypernatremia and dehydration, and occasional drooling.

1. This product is contraindicated for patients with Hirschsprung's disease, intestinal obstruction, ascites, congestive heart disease or renal failure. 2. This product is contraindicated for use with other laxatives. 3. This product is contraindicated for patients who are allergic to sodium phosphate and other ingredients.

Precautions for children: This product is not recommended for children. Precautions for pregnancy and lactation: Pregnant and lactating women should consult a physician before taking the drug. Precautions for the elderly: Not yet clear.

This product should be used with caution in patients taking calcium channel blockers, diuretics, and other medications that may affect electrolyte levels. This product should be used with caution in patients taking calcium channel blockers, diuretics, and other medications that may affect electrolyte levels.

Store in a sealed container below 25°C.

45ml (containing 21.6g sodium dihydrogen phosphate, 8.1g disodium hydrogen phosphate)

24 months

Shanghai Haihong Industry (Group) Chaohu Jinchen Pharmaceutical Co., Ltd.

• Founded in:

  2002-11-26

• Address:

  No. 18, Yicheng Road, Chaohu City, Anhui Province

• Tax NO.:

  91340181744869155N

• Registered Funds:

  31 million yuan

• Website:

  Log in to view

• Email:

  Log in to view